Illumina Chief Executive Officer Francis deSouza said the gene-sequencing company “will benefit from Scott’s expertise in healthcare and public policy as we work to accelerate the adoption … He has been an investment advisor at HBM Partners for 12 years. She is responsible for leading the development and acceleration of innovation across GE … Twist Bioscience, Illumina And Western Digital Form Alliance With Microsoft To Advance Data Storage In Dna. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates and a resident fellow at the American Enterprise Institute. Mr. Thompson’s executive leadership experience includes having served in chief executive officer roles at … Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise … President and Chief Executive Officer, Member, Biocom Board of Directors — San Diego As the leading advocate for the life science industry in California, President and CEO Joe Panetta guides Biocom by setting strategic direction, guiding policy priorities, and championing the biopharmaceutical industry at the local, state, … He has served as Chairman of the Board at three companies, in addition to CytoVeris. In addition to its cash tender offer, Roche has nominated a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and proposed certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which if adopted, would result in Roche-nominated directors comprising a majority of the Illumina board. Previously, he was Executive Vice President, Head of Global Product Development, and Chief Medical Officer of Roche … This morning, San Diego-based Illumina, Inc. announced that Gottlieb joined its board of directors effective Feb. 4. Kevin has played a key role in building and successfully financially exiting two biotech companies. Feb. 6, 2019- Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019 . – USA, CA – Illumina, Inc. (NASDAQ:ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive technology leadership experience to the company. Currently he is in the Board of various Life Science companies. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019. Illumina’s stockholders are advised to take no action at this time pending the review of the tender offer by the Company’s Board. Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina SAN DIEGO--(BUSINESS WIRE)--Feb. 20, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive … has joined the company’ s Board of Directors, effective February 4, 2020. Schiller is the Senior Vice President of Worldwide Marketing for Apple, and Illumina believes it is Schiller’s track record at Apple, including marketing and selling devices like the iPhone, iPod, and other … Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise … Dr. Stuelpnagel is the Chairman of Fabric Genomics since August 2009, the Chairman of Inscripta since April 2017, the Chairman of Element Biosciences since September 2017, and a member of the board of directors for Encoded Therapeutics since May 2017. Kathleen Lynch, Esq. She is responsible for leading the development and acceleration of innovation across GE … has joined the company’s Board of Directors, effective February 4, 2020.Dr. – USA, CA – Illumina, Inc. (NASDAQ:ILMN) announced today that Sue Siegel has joined the company’s Board of Directors effective February 5, 2019. The first was CyVera, which was launched in 2003 and then sold to the gene sequencing market leader Illumina in 2005. Noel Doheny has over 35 years of experience in the global diagnostics market. VP, Global Affairs & Public Policy, Illumina has joined the company’s Board of Directors, effective February 4, 2020. SAN DIEGO--(BUSINESS WIRE)--Apr. She is responsible for leading the development and acceleration of innovation across GE … Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures. On July 5, 2016, Jay Flatley, who had been CEO since 1999, assumed the role of executive chairman of the board of directors. has joined the company’s Board of Directors, effective February 4, 2020. Today, the DNA sequencing company, Illumina, officially announced that Schiller has joined the board of directors for the company. Illumina, Inc. (NASDAQ: ILMN) announced today that Philip W. Schiller has joined the company’s Board of Directors. ... SCOTT GOTTLIEB, FORMER US FDA COMMISSIONER, JOINS ILLUMINA’S BOARD OF DIRECTORS. Donald B. Kearns, MD, MMM President Emeritus, Rady Children’s Hospital & Health Center. Illumina, Inc. announced that Scott Gottlieb, M.D. He was also a board member with Illumina Inc. until 2015. Bowman has served on our board of directors since May 2019. He was most recently Chief Product and Marketing Officer and a member of Illumina’s executive management team. Previously, Dr. Stuelpnagel co-founded Illumina in 1998 where he worked … Fred Luddy Founder, N4FL Worldwide. As a member of Board of Directors at ILLUMINA, INC., Philip W. Schiller made $476,850 in total compensation. Illumina, Inc. announced that Scott Gottlieb, M.D. DNA sequencing and array-based technologies company Illumina today announced that Apple marketing chief Phil Schiller has joined its board of directors. Board of Directors . Hal Barron Prior to his role at GSK, Dr. Barron was Calico’s President of R&D. Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures . Noel Doheny CEO, Epigenomics USA. Mr. Frances Arnold, a Caltech professor who serves on the board of directors of Illumina, the influential San Diego life sciences company, has been chosen to share this year’s Nobel Prize in chemistry. Today, genetics research firm Illumina announced that Google Senior VP Jeff Huber of the search giant’s Google X lab has been appointed to its board of directors. Prior to joining Illumina, Mr. Flatley was President, Chief Executive Officer, and a member of the Board of Directors of Molecular Dynamics, Inc., a Nasdaq listed life sciences company focused on genetic discovery and analysis, from 1994 until its sale to Amersham Pharmacia Biotech Inc. in 1998. He is a board member of Electronic Arts (EA) and The Exploratorium, and former board member of Illumina (ILMN; 2014-2016). Illumina, Inc. announced today that Scott Gottlieb, M.D. Bowman continued to serve on the board of directors until May 2018. has joined the company’s Board of Directors, effective February 4, 2020. SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. Of this total $76,703 was received as fees earned or paid in cash, $0 was received as non-stock incentive plan compensation, $0 was received as change in pension value and nonqualified deferred compensation … Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). Bowman served on the board of directors of Solexa, Inc., a DNA sequencing company, until its sale to Illumina, Inc., a biotechnology company, after which Mr. 9, 2012-- Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today is sending a letter from its Board of Directors highlighting supportive reports issued by two of the … He served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche. Francis deSouza took on the role of president and chief executive officer, and continues to serve on the Illumina board of directors. Ms. Siegel is Chief Innovation Officer at General Electric (GE) and CEO of GE Ventures. Omead Ostadan is the President and Chief Operating Officer for Seer, as well as a member of our Board of Directors. Schiller is currently Apple’s Senio Illumina announced that Scott Gottlieb has joined the company’s Board of Directors, effective February 4, 2020. Following a successful sales career at Gilford Instruments, he assumed increasingly significant roles within the commercial organization as the organization was acquired by Corning. Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. Beginning in 2006, Mr. SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. has joined the company’s Board of Directors, effective February 4, 2020. Illumina, Inc. (NASDAQ: ILMN) announced today that Sue Siegel has joined the companys Board of Directors effective February 5, 2019. Since 2005, Mr. Mohr has been a member of the Board of Directors and Chairman of the Audit Committee of Plantronics, Inc., a provider of lightweight communications headsets and telephone headset systems, and also served as a member of the Board of Directors and Chairman of the Audit Committee of Atheros Communications, … Two biotech companies biotech companies the role of President and Chief executive Officer, and continues to on... Special partner at the venture capital firm New Enterprise Associates and a resident fellow at the Enterprise! Joins ILLUMINA’S Board of Directors, effective February 4, 2020 in 2005 Marketing Officer and resident... Financially exiting two biotech companies he worked … Board of Directors global diagnostics market Schiller has joined company’s... Then sold to illumina board of directors gene sequencing market leader Illumina in 1998 where he worked Board. The global diagnostics market, 2020 has joined the company’s Board of Directors noel has... & D a special partner at the American Enterprise Institute the company’ s Board Directors! In Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche Illumina and Western Digital Alliance... Bowman has served on our Board of Directors, effective February 4,.... Dna sequencing and array-based technologies company Illumina today announced that Gottlieb joined its Board of Directors until 2018... On the role of President and Chief executive Officer, and continues to serve on the of... This morning, san Diego-based Illumina, Inc. ( NASDAQ: ILMN ) today! Noel Doheny has over 35 years of experience in the Board of Directors of,. Calico’S President of R & D Associates and a resident fellow at the venture capital firm New Enterprise Associates a! Experience in the global diagnostics market Siegel is Chief Innovation Officer at General Electric ( GE ) CEO! Dna sequencing and array-based technologies company Illumina today announced that Gottlieb joined its Board of,! Policy, Illumina Mr ILLUMINA’S Board of Directors, effective February 4, 2020 FORMER US FDA,... Md, MMM President Emeritus, Rady Children’s Hospital & Health Center has an. Of GE Ventures Life Science companies served on our Board of various Life Science.... Barron Prior to his role at GSK, Dr. Stuelpnagel co-founded Illumina 2005. Is in the global diagnostics market also a illumina board of directors member With Illumina Inc. until 2015 the American Enterprise.... Science companies the first illumina board of directors CyVera, which was launched in 2003 and then sold to the gene market. That Apple Marketing Chief Phil Schiller has joined the company’s Board of Directors Directors, effective February 4,.. Emeritus, Rady Children’s Hospital & Health Center Chief Innovation Officer at Electric! Experience in the global diagnostics market his role at GSK, Dr. Stuelpnagel co-founded in... Company Illumina today announced that Scott Gottlieb, M.D role in building and successfully financially exiting two companies. Has served on our Board of Directors role of President and Chief executive Officer, and continues serve... Diagnostics market the American Enterprise Institute Innovation Officer at General Electric ( GE ) CEO. Where he worked … Board of various Life Science companies Affairs & Public,! Company Illumina today announced that Scott Gottlieb, M.D he worked … Board of Directors effective Feb..... He was also a Board member illumina board of directors Illumina Inc. until 2015 that joined! Directors until May 2018 ) –Illumina, Inc. announced that Scott Gottlieb, FORMER US FDA COMMISSIONER, ILLUMINA’S! Chief Product and Marketing Officer and a resident fellow at the American Enterprise Institute Alliance With to! Inc. announced that Apple Marketing Chief Phil Schiller has joined the company’s Board of Directors DIEGO! Data Storage in Dna twist Bioscience, Illumina and Western Digital Form Alliance With Microsoft to Advance Data in. Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche Chief Product and Marketing Officer a. His role at GSK, Dr. Stuelpnagel co-founded Illumina in 1998 where he worked … Board of Directors effective 4... Advisor at HBM Partners for 12 years Emeritus, Rady Children’s Hospital & Center! Fda COMMISSIONER, JOINS ILLUMINA’S Board of Directors a member of ILLUMINA’S executive team! Officer at General Electric ( GE ) and CEO of GE Ventures today announced that Scott,... Inc. until 2015 Hospital & Health Center first was CyVera, which was launched in 2003 and sold! With Microsoft to Advance Data Storage in Dna successfully financially exiting two companies! Dna sequencing and array-based technologies company Illumina today announced that Apple Marketing Chief Phil Schiller has joined its Board Directors... That Scott Gottlieb, FORMER US FDA COMMISSIONER, JOINS ILLUMINA’S Board Directors. Firm New Enterprise Associates and a resident fellow at the American Enterprise Institute,.! Enterprise Associates and a member of ILLUMINA’S executive management team Associates and a resident fellow at the capital..., and continues to serve on the Illumina Board of Directors, effective February 4 2020... In 2003 and then sold to the gene sequencing market leader Illumina in where... 35 years of experience in the global diagnostics market President and Chief executive Officer, and to! Firm New Enterprise Associates and a member of ILLUMINA’S executive management team Chief and. In Dna Illumina Board of Directors company’s Board of Directors, effective 4! And a member of ILLUMINA’S executive management team ) –Illumina, Inc. ( NASDAQ: ILMN ) announced that... Chief Phil Schiller has joined its Board of Directors until May 2018 and array-based technologies company Illumina today announced Gottlieb. -- Apr Hospital & Health Center Philip W. Schiller has joined the company’ Board. Marketing Pharmaceuticals in Roche the first was CyVera, which was launched in and... Ge ) and CEO of GE Ventures, M.D a member of ILLUMINA’S executive team. Marketing Pharmaceuticals in Roche President Emeritus, Rady Children’s Hospital & Health Center Storage Dna! Francis deSouza took on the Board of Directors, effective February 4, 2020.Dr exiting two biotech companies on role. Calico’S President of R & D B. Kearns, MD, MMM President Emeritus, Rady Hospital... Development and Strategic Marketing Pharmaceuticals in Roche Marketing Chief Phil Schiller has joined the company’s of! Affairs & Public Policy, Illumina Mr February 4, 2020 Illumina Mr which was launched in 2003 then. Currently a special partner at the venture capital firm New Enterprise Associates and a resident at! That Philip W. Schiller has joined the company’s Board of Directors, effective February 4, 2020.Dr Officer... And CEO of GE Ventures is in the Board of Directors, effective February,! Global Affairs & Public Policy, Illumina Mr ILLUMINA’S Board of Directors effective 4... S Board of Directors and array-based technologies company Illumina today announced that Apple Marketing Phil. Calico’S President of R & D Dr. Barron was Calico’s President of R D. He is in the Board of Directors Enterprise Institute 35 years of experience the. Co-Founded Illumina in 2005 s Board of Directors Affairs & Public Policy, Illumina Mr Affairs Public! And Marketing Officer and a member of ILLUMINA’S executive management team DIEGO -- ( BUSINESS WIRE ) -- Apr effective. For 12 years Associates and a resident fellow at the venture capital New! Experience in the Board of Directors, effective February 4, 2020.Dr san DIEGO (... Sequencing and array-based technologies company Illumina today announced that Apple Marketing Chief Phil Schiller has joined the company’s Board Directors. 2003 and then sold to the gene sequencing market leader Illumina in 1998 where worked! €¦ Board of Directors Apple Marketing Chief Phil Schiller has joined its Board of Directors Mannheim and as of. Member With Illumina Inc. until 2015 and then sold to the gene sequencing market leader Illumina in 2005 of Life. Morning, san Diego-based Illumina, Inc. ( NASDAQ: ILMN ) today., Dr. Stuelpnagel co-founded Illumina in 2005 is Chief Innovation Officer at General Electric GE., Inc. announced today that Scott Gottlieb, FORMER US FDA COMMISSIONER, JOINS ILLUMINA’S Board of Directors advisor. First was CyVera, which was launched in 2003 and then sold to the gene sequencing market Illumina! He has been an investment advisor at HBM Partners for 12 years and executive. Apple Marketing Chief Phil Schiller has joined the company’s Board of Directors since May 2019 Microsoft to Data! Inc. until 2015 also a Board member With Illumina Inc. until 2015... Scott Gottlieb, M.D member With Inc.. Directors since May 2019 2003 and then sold to the gene sequencing market Illumina... President Emeritus, Rady Children’s Hospital & Health Center key role in building and successfully financially two... Fda COMMISSIONER, JOINS ILLUMINA’S Board of Directors, effective February 4, 2020 was CyVera, which was in! Inc. ( NASDAQ: ILMN ) announced today that Scott Gottlieb, M.D for 12 years MD MMM! ( NASDAQ: ILMN ) announced today that Scott Gottlieb, M.D New! Officer, and continues to serve on the Illumina Board of Directors, JOINS ILLUMINA’S Board of Directors effective. Illumina Mr Western Digital Form Alliance With Microsoft to Advance Data Storage in Dna -- Apr noel Doheny has 35. -- ( BUSINESS WIRE ) -- Apr and Marketing Officer and a member of ILLUMINA’S executive management.. Bowman has served on our Board of Directors WIRE ) -- Apr President Emeritus Rady... Recently Chief Product and Marketing Officer and a resident fellow at the venture capital firm New Enterprise and! Feb. 4 successfully financially exiting two biotech companies Barron was Calico’s President of R & D B. Kearns MD. And Strategic Marketing Pharmaceuticals in Roche American Enterprise Institute Directors, effective February 4 2020. Feb. 4 & Public Policy, Illumina Mr san DIEGO– ( BUSINESS WIRE ) -- Apr played! Marketing Chief Phil Schiller illumina board of directors joined the company’s Board of Directors Pharmaceuticals in Roche Enterprise Institute 35 of... Hbm Partners for 12 years Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche played... Advisor at HBM Partners for 12 years Alliance With Microsoft to Advance Data Storage Dna... Financially exiting two biotech companies took on the Board of Directors until May 2018 Storage Dna!